Rachael Nokes - 11 Feb 2025 Form 4 Insider Report for scPharmaceuticals Inc. (SCPH)

Role
CFO and Treasurer
Signature
/s/ Rachael Nokes
Issuer symbol
SCPH
Transactions as of
11 Feb 2025
Net transactions value
$0
Form type
4
Filing time
12 Feb 2025, 16:27:03 UTC
Previous filing
07 Jan 2025
Next filing
07 Oct 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SCPH Common Stock Award $0 +88,445 +131% $0.000000 156,061 11 Feb 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SCPH Stock Option (Right to Buy) Award $0 +132,670 $0.000000 132,670 11 Feb 2025 Common Stock 132,670 $3.34 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of a restricted stock unit ("RSU") award made pursuant to the scPharmaceuticals Inc. 2017 Stock Option and Incentive Plan. The RSUs vest as to 25% of the shares underlying the RSUs on each of the first four anniversaries of January 1, 2025, such that the RSUs will be fully vested on January 1, 2029.
F2 The option shares vest over a four-year period, at a rate of 25% on January 1, 2026, with the remaining option shares vesting in 36 equal monthly installments thereafter, such that the option shares will be fully vested on January 1, 2029.